UmbREALung - A Retrospective and prospective, observational, real world multi-cohort study of patients with non-small cell lung cancer (NSCLC) initiating approved drugs developed by AZ or as part of an AZ alliance

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Country	Location
France	AIX EN PROVENCE, France
France	ANGERS, France
France	AURILLAC, France
France	AUXERRE, France
France	AVIGNON, France
France	BLOIS, France
France	BORDEAUX, France
France	BOURG EN BRESSE, France
France	CARCASSONNE, France
France	Chalon sur Saone, France
France	Chambery, France
France	CHATEAUROUX, France
France	CRETEIL, France
France	DIEPPE, France
France	DINAN, France
France	DREUX, France
France	Epagny Metz Tessy, France
France	Le COUDRAY, France
France	LIMOGES, France
France	Lyon, France
France	LYON, France
France	MARSEILLE, France
France	MEAUX, France
France	METZ, France
France	MULHOUSE, France
France	NANCY, France
France	NANTES, France
France	NEUILLY SUR SEINE, France
France	NICE, France
France	Nîmes, France
France	PERPIGNAN, France
France	ST BRIEUC, France
France	ST ETIENNE, France
France	ST HERBLAIN, France
France	SURESNES, France
France	TOULOUSE, France
France	TROYES, France
France	VALENCIENNES, France
France	VANNES, France
France	VILLEFRANCHE SUR SAONE, France
France	VILLEURBANNE, France